preconception counselling
Disease control at conception predicts outcome. Three moves: (1) defer conception until optimised, with effective contraception meanwhile; (2) swap teratogens and start folic acid (0.4 / 1 / 4–5 mg by risk); (3) plan care — MFM ± subspecialist referral, aspirin eligibility, “tell me as soon as you’re pregnant”.
mWHO 2.0 IV: PAH, LVEF <30% or NYHA III–IV, prior PPCM with > mild residual LV impairment, severe MS, symptomatic severe AS, Marfan/HTAD aorta >45 mm (BAV >50), vascular EDS, Eisenmenger. Also defer: mechanical valve (mWHO III) without anticoagulation plan, active lupus nephritis/SLE flare within 6 months, HbA1c >10%, uncontrolled epilepsy on valproate, eGFR <30 or recent transplant (<1 y).
folic acid (SOGC)
| risk | dose |
|---|---|
| low | 0.4 mg/d in a multivitamin (with B12 + iron), from 2–3 months pre-conception through pregnancy and breastfeeding |
| moderate — pre-gestational T1/T2DM, antiseizure drugs (AAN 2024: ≥0.4 mg), malabsorption (IBD, coeliac, bariatric), anti-folate drugs (MTX, sulfasalazine), dialysis, second-degree relative with NTD, BMI >30 (consider serum folate) | 1 mg/d pre-conception to 12 wk, then 0.4 mg |
| high — prior NTD pregnancy (either parent), personal NTD, or first-degree relative with NTD | 4–5 mg/d pre-conception to 12 wk (or dose by serum folate), then 0.4 mg |
by condition
| condition | key preconception actions | main risks |
|---|---|---|
| chronic HTN | replace ACEi/ARB when planning pregnancy (at positive test if compelling indication, e.g. proteinuria); labetalol/nifedipine; baseline uPCR, Cr | superimposed preeclampsia, FGR, abruption — chronic hypertension in pregnancy |
| T1/T2DM | HbA1c ≤7% (ideally ≤6.5%); retinal exam, uACR; stop non-insulin agents except metformin/glyburide; folate 1 mg | anomalies, stillbirth 3–5×, macrosomia, preeclampsia — diabetes in pregnancy |
| prior preeclampsia | aspirin 162 mg qhs before 16 wk; exercise ≥150 min/wk; BP, lipids, glucose screen | recurrence ~1 in 6; ~25% if prior <34 wk, ~50% if <28 wk |
| prior GDM | screen for T2DM; weight, activity | ~50% recurrence |
| epilepsy | switch from valproate/topiramate; baseline levels; folate | MCM, seizures if under-dosed — epilepsy in pregnancy |
| heart disease | echo, mWHO class, cardio-obstetrics; intervene on severe stenosis | HF, arrhythmia — heart disease in pregnancy |
| prior VTE | plan antepartum/postpartum LMWH | recurrence 5–10% without prophylaxis — VTE in pregnancy |
| SLE / APS | quiescent ≥6 months; continue HCQ; stop MMF >6 wk and MTX 1–3 months pre-conception; anti-Ro/La, aPL | flare, preeclampsia, congenital heart block (anti-Ro → foetal echo 16–26 wk) |
| IBD | steroid-free remission ≥3 months; continue 5-ASA, azathioprine, anti-TNF; stop MTX ≥3 months | flare (active at conception ~⅔ flare vs ~⅓ in remission), preterm birth |
| CKD | eGFR, proteinuria, BP control; stop ACEi at positive test | preeclampsia, CKD progression if Cr >125 µmol/L |
| thyroid | levothyroxine-treated → ↑ dose ~25–30% (2 extra tablets/wk) at positive test; aim euthyroid preconception (ATA 2026); switch methimazole → PTU before 16 wk if hyperthyroid | miscarriage, preeclampsia, preterm birth, neurodevelopmental delay — thyroid disease in pregnancy |
| obesity (BMI >30) | weight loss pre-conception; 1 mg folate; screen for DM/OSA | GDM, preeclampsia, VTE, NTD, stillbirth, CS |
lifestyle and general
- Stop smoking, alcohol, cannabis
- Exercise: ≥150 min/wk moderate intensity over ≥3 days throughout pregnancy unless contraindicated (SOGC: ~40% ↓ GDM, gestational HTN, preeclampsia)
- Vaccinate pre-conception: MMR, varicella if non-immune (then wait 4 wk); HBV, influenza, COVID
- Medication review against teratogen list — prescribing in pregnancy and lactation
- Statins: stop when planning pregnancy for primary prevention; continuation may be considered with FH or established ASCVD (ESC 2025)
obesity in pregnancy
- Gestational weight gain (IOM, BMI ≥30): 5–9 kg
- BMI >30 = high-risk factor for preeclampsia (SOGC 2022) → aspirin; early GDM screen
- Anaesthesia consult antenatally (BMI ≥40); postpartum thromboprophylaxis after CS
- Postpartum: depression screening, lactation support
IBD in pregnancy
- Mode of delivery obstetric — except active perianal Crohn’s (→ CS) and IPAA (discuss)
- Flare: prednisone, 5-ASA, anti-TNF (GI-led)
- Anti-TNF-exposed infants: rotavirus on schedule; delay BCG 6 months if infliximab/adalimumab/golimumab after 20 wk (etanercept after 32 wk); certolizumab — no change
- Non-TNF biologics (e.g. ustekinumab) in T2–T3 → delay all live vaccines 6 months
- Chronic steroids: stress-dose for caesarean, not routinely for vaginal delivery (ACR, conditional)
“The better your condition is controlled before conception, the safer the pregnancy is for you and the baby. Until then, use reliable contraception. When you’re ready, start folic acid three months ahead, and tell me as soon as you’re pregnant so I can refer you to maternal–foetal medicine.”
Prepared 2026-10-15. Not yet verified — check every number against the sources.